Document Detail


Effect of modest alcohol consumption over 1-2 weeks on the coronary microcirculation of normal subjects.
MedLine Citation:
PMID:  20378684     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIMS: It has been reported that imbibing red wine increases coronary blood flow reserve acutely. In the absence of changes in coronary driving pressure, any increases in coronary blood flow reserve should occur through a decrease in capillary resistance, which in turn is determined by capillary dimensions and whole-blood viscosity. Since alcohol intake is unlikely to acutely change capillary dimensions, we hypothesized that it must increase coronary blood flow reserve by reducing whole-blood viscosity.
METHODS AND RESULTS: Forty-five normal subjects were randomly assigned to water (n = 12), vodka (n = 11), white wine (n = 11), and red wine (n = 11). Myocardial blood flow reserve was measured at baseline and after up to 2 weeks of beverage consumption using myocardial contrast echocardiography. In addition, whole-blood viscosity and its principal determinants (haematocrit; erythrocyte deformability, mobility, and charge; plasma fibrinogen; and total serum protein, glucose, and lipids) were also measured. Systolic and diastolic blood pressure and heart rate did not change between the two examinations either at rest or following dipyridamole infusion. Neither did myocardial blood flow reserve nor whole-blood viscosity or any of its determinants. Only high-density lipoprotein-2 increased for all alcohol consumers (12.4 +/- 5.3 vs. 10.9 +/- 4.7, P = 0.007).
CONCLUSION: It is concluded that modest alcohol consumption for up to 2 weeks does not increase myocardial blood flow reserve. It also does not alter whole-blood viscosity or any of its principal determinants. Therefore, the beneficial cardiovascular effects of modest alcohol consumption over 1-2 weeks cannot be attributed either to its effect on the coronary microcirculation or haemorheology.
Authors:
Sanjiv Kaul; Todd Belcik; Saul Kalvaitis; Ananda R Jayaweera; Si-Wan Choi; Kevin Wei
Related Documents :
10877534 - Effects of a novel vesamicol receptor ligand, m-(iodobenzyl)trozamicol, on the canine i...
2919764 - Influence of nifedipine on systemic and regional hemodynamics during adenosine-induced ...
3759804 - Changes in coronary flow following repeated brief coronary occlusion in the conscious dog.
1259684 - Transmural differences in myocardial blood flow and in coronary dilatory capacity in he...
3879534 - The use of a vasoconstrictor to improve tumour blood flow in intra-arterial chemotherap...
12546154 - A new high resolution color flow system using an eigendecomposition-based adaptive filt...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural     Date:  2010-04-08
Journal Detail:
Title:  European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology     Volume:  11     ISSN:  1532-2114     ISO Abbreviation:  Eur J Echocardiogr     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-08     Completed Date:  2011-06-02     Revised Date:  2011-09-13    
Medline Journal Info:
Nlm Unique ID:  100890618     Medline TA:  Eur J Echocardiogr     Country:  England    
Other Details:
Languages:  eng     Pagination:  683-9     Citation Subset:  IM    
Affiliation:
Cardiovascular Medicine Division, UHN 62, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA. kauls@ohsu.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Alcohol Drinking*
Coronary Circulation / drug effects
Diastole / drug effects
Dipyridamole / pharmacology
Echocardiography
Erythrocytes / drug effects
Ethanol / pharmacology*
Female
Fractional Flow Reserve, Myocardial / drug effects*
Hemodynamics / drug effects
Humans
Logistic Models
Male
Microcirculation / drug effects*
Multivariate Analysis
Myocardium*
Phosphodiesterase Inhibitors / pharmacology
Systole / drug effects
Vasodilator Agents / pharmacology
Grant Support
ID/Acronym/Agency:
R01 EB-002069/EB/NIBIB NIH HHS
Chemical
Reg. No./Substance:
0/Phosphodiesterase Inhibitors; 0/Vasodilator Agents; 58-32-2/Dipyridamole; 64-17-5/Ethanol
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Influence of left ventricular hypertrophy on microvascular dysfunction and left ventricular remodell...
Next Document:  Non-invasive coronary flow reserve after successful primary angioplasty for acute anterior myocardia...